Skip to main content
OpenTrials

Clinical trial condition

Macular Edema

Explore clinical trials studying Macular Edema. Study availability and eligibility vary by location and protocol.

298 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Macular Edema trial results

Completed

A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema

NCT01315275

Conditions
Eye Diseases, Macular Degeneration, Macular Edema, +9 more
Locations
  • Novartis Investigative Site Paris, France
  • Novartis Investigative Site Amiens, France
  • Novartis Investigative Site Angers, France
  • Novartis Investigative Site Besançon, France
View all 43 locations
View Trial Details
Completed

Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion

NCT01377597

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +14 more
Locations
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Fukuoka, Japan
  • Novartis Investigative Site Kita-gun, Kagawa-ken, Japan
View Trial Details
Completed

Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion

NCT01599650

Conditions
Branch Retinal Vein Occlusion, Cardiovascular Diseases, Embolism and Thrombosis, +15 more
Locations
  • Novartis Investigative Site Parramatta, New South Wales, Australia
  • Novartis Investigative Site Sydney, New South Wales, Australia
  • Novartis Investigative Site Melbourne, Victoria, Australia
  • Novartis Investigative Site Nedlands, Western Australia, Australia
View all 82 locations
View Trial Details
Completed

Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion

NCT01535261

Conditions
Cardiovascular Diseases, Central Retinal Vein Occlusion, Embolism and Thrombosis, +9 more
Locations
  • Novartis Investigative Site Parramatta, New South Wales, Australia
  • Novartis Investigative Site Sydney, New South Wales, Australia
  • Novartis Investigative Site Melbourne, Victoria, Australia
  • Novartis Investigative Site Nedlands, Western Australia, Australia
View all 78 locations
View Trial Details
Completed

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

NCT01396083

Conditions
Cardiovascular Diseases, Central Retinal Vein Occlusion, Embolism and Thrombosis, +16 more
Locations
  • Novartis Investigative Site Leipzig, Germany
  • Novartis Investigative Site Regensburg, Germany
  • Novartis Investigative Site Augsburg, Germany
  • Novartis Investigative Site Bad Rothenfelde, Germany
View all 64 locations
View Trial Details

Related conditions